Jieqiong You, Jieqiong You, Jieqiong You, Ying Wang, Ying Wang, Haifeng Chen, . . . Fang Jin. (2023). RIPK2: A promising target for cancer treatment. Frontiers Media S.A..
Chicago Style (17th ed.) CitationJieqiong You, Jieqiong You, Jieqiong You, Ying Wang, Ying Wang, Haifeng Chen, Fang Jin, and Fang Jin. RIPK2: A Promising Target for Cancer Treatment. Frontiers Media S.A., 2023.
MLA (9th ed.) CitationJieqiong You, et al. RIPK2: A Promising Target for Cancer Treatment. Frontiers Media S.A., 2023.
Warning: These citations may not always be 100% accurate.